# Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

> **NCT02997423** · — · COMPLETED · sponsor: **University of Iowa** · enrollment: 153 (actual)

## Conditions studied

- Glioblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02997423
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-30
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2023-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02997423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02997423, "Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02997423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*